Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe/PS1dE9 transgenic mice

Alzheimer's Research and Therapy

Volumn 4, Issue 2, 2012, Pages

  Xu, Guilian ^a   Green, Cameron C ^a,b   Fromholt, Susan E ^a   Borchelt, David R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CRE RECOMBINASE; GLIAL FIBRILLARY ACIDIC PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOXP SITE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGRESSION ANALYSIS; STUDENT T TEST; TRANSGENIC MOUSE;

EID: 84860165507     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt110     Document Type: Article

References (38)

1. Lipoprotein receptors in Alzheimer's disease. Andersen OM, Willnow TE, Trends Neurosci 2006 29 687 694 10.1016/j.tins.2006.09.002 17000013 (Pubitemid 44779850)
2. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Rebeck GW, Reiter JS, Strickland DK, Hyman BT, Neuron 1993 11 575 580 10.1016/0896-6273(93)90070-8 8398148 (Pubitemid 23321768)
3. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. Bu G, Maksymovitch EA, Nerbonne JM, Schwartz AL, J Biol Chem 1994 269 18521 18528 7518435 (Pubitemid 24224088)
4. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density- lipoprotein receptor-related protein. Rebeck GW, Harr SD, Strickland DK, Hyman BT, Ann Neurol 1995 37 211 217 10.1002/ana.410370212 7531418
5. Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. Marzolo MP, von Bernhardi R, Bu G, Inestrosa NC, J Neurosci Res 2000 60 401 411 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L 10797543 (Pubitemid 30253604)
6. Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP. Rebeck GW, Moir RD, Mui S, Strickland DK, Tanzi RE, Hyman BT, Brain Res Mol Brain Res 2001 87 238 245 11245926 (Pubitemid 32195475)
7. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y, Neuron 1994 13 45 53 10.1016/0896-6273(94)90458-8 8043280
8. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH, J Neurosci 2004 24 4259 4265 10.1523/JNEUROSCI.5451-03.2004 15115822 (Pubitemid 38620802)
9. Clearing amyloid through the blood-brain barrier. Zlokovic BV, J Neurochem 2004 89 807 811 10.1111/j.1471-4159.2004.02385.x 15140180 (Pubitemid 38684728)
10. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Deane R, Wu Z, Zlokovic BV, Stroke 2004 35 2628 2631 10.1161/01.STR.0000143452.85382. d1 15459432 (Pubitemid 39458354)
11. Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-Demotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA, J Alzheimers Dis 2009 17 553 570 19433890
12. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R, Neurology 1997 49 56 61 10.1212/WNL.49.1.56 9222170 (Pubitemid 27328682)
13. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH, J Clin Invest 2000 106 1159 1166 10.1172/JCI11013 11067868
14. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V, Proc Natl Acad Sci USA 2012 109 3510 3515 10.1073/pnas. 1112209109 22308347
15. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis. Van Uden E, Kang DE, Koo EH, Masliah E, Microsc Res Tech 2000 50 268 272 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3. 0.CO;2-1 10936878 (Pubitemid 30651164)
16. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. Narita M, Bu G, Holtzman DM, Schwartz AL, J Neurochem 1997 68 587 595 9003044 (Pubitemid 27044718)
17. Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. Qiu Z, Strickland DK, Hyman BT, Rebeck GW, J Neurochem 1999 73 1393 1398 10501182 (Pubitemid 29440138)
18. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV, J Clin Invest 2000 106 1489 1499 10.1172/JCI10498 11120756 (Pubitemid 32038587)
19. LRP: a multifunctional scavenger and signaling receptor. Herz J, Strickland DK, J Clin Invest 2001 108 779 784 11560943 (Pubitemid 32880284)
20. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT, Ann Neurol 2000 47 739 747 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0. CO;2-8 10852539 (Pubitemid 30390194)
21. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Herz J, Clouthier DE, Hammer RE, Cell 1992 71 411 421 10.1016/0092-8674(92)90511-A 1423604
22. Receptor-associated protein (RAP) plays a central role in modulating Abeta deposition in APP/PS1 transgenic mice. Xu G, Karch C, Li N, Lin N, Fromholt D, Gonzales V, Borchelt DR, PLoS One 2008 3 3159 10.1371/journal.pone. 0003159 18776935
23. Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E, J Neurosci 2002 22 9298 9304 12417655 (Pubitemid 35356173)
24. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Willnow TE, Armstrong SA, Hammer RE, Herz J, Proc Natl Acad Sci USA 1995 92 4537 4541 10.1073/pnas.92.10.4537 7538675
25. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Zerbinatti CV, Wozniak DF, Cirrito J, Cam JA, Osaka H, Bales KR, Zhuo M, Paul SM, Holtzman DM, Bu G, Proc Natl Acad Sci USA 2004 101 1075 1080 10.1073/pnas.0305803101 14732699 (Pubitemid 38160586)
26. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, Messing A, Genesis 2001 31 85 94 10.1002/gene.10008 11668683 (Pubitemid 33064319)
27. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP, Nature 2002 418 422 425 10.1038/nature00838 12140559 (Pubitemid 34826842)
28. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Rohlmann A, Gotthardt M, Willnow TE, Hammer RE, Herz J, Nat Biotechnol 1996 14 1562 1565 10.1038/nbt1196-1562 9634821 (Pubitemid 26365549)
29. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. Rohlmann A, Gotthardt M, Hammer RE, Herz J, J Clin Invest 1998 101 689 695 10.1172/JCI1240 9449704 (Pubitemid 28084254)
30. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR, Biomol Eng 2001 17 157 165 10.1016/S1389-0344(01)00067-3 11337275 (Pubitemid 32409891)
31. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Lesuisse C, Xu G, Anderson J, Wong M, Jankowsky J, Holtz G, Gonzalez V, Wong PC, Price DL, Tang F, Wagner S, Borchelt DR, Hum Mol Genet 2001 10 2525 2537 10.1093/hmg/10.22.2525 11709540 (Pubitemid 33095003)
32. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH, Price DL, Sisodia SS, Cleveland DW, Proc Natl Acad Sci USA 1994 91 8292 8296 10.1073/pnas.91.17.8292 8058797 (Pubitemid 24253933)
33. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Guntern R, Bouras C, Hof PR, Vallet PG, Experientia 1992 48 8 10 10.1007/BF01923594 1371102
34. Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L, Borchelt DR, Hum Mol Genet 2011 20 2770 2782 10.1093/hmg/ddr176 21515588
35. Silver impregnation of nerve cells and fibers in celloidin sections. A simple impregnation technique. Hirano A, Zimmerman HM, Arch Neurol 1962 6 114 122 10.1001/archneur.1962.00450200028003 13907612
36. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Yamamoto T, Hirano A, Neuropathol Appl Neurobiol 1986 12 3 9 10.1111/j.1365-2990.1986.tb00677.x 2422580 (Pubitemid 16168220)
37. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. Bu G, Geuze HJ, Strous GJ, Schwartz AL, Embo J 1995 14 2269 80 7774585
38. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL, Proc Natl Acad Sci USA 1995 92 9480 9484 10.1073/pnas.92.21.9480 7568158